European Psychiatry (Jun 2022)

Health Services Use and Costs in Individuals with Autism Spectrum Disorder in Germany: Results from a Survey in ASD Outpatient Clinics

  • J. Höfer,
  • F. Hoffmann,
  • M. Dörks,
  • I. Kamp-Becker,
  • C. Küpper,
  • L. Poustka,
  • S. Roepke,
  • V. Roessner,
  • S. Stroth,
  • N. Wolff,
  • C. Bachmann

DOI
https://doi.org/10.1192/j.eurpsy.2022.1072
Journal volume & issue
Vol. 65
pp. S422 – S422

Abstract

Read online

Introduction Autism spectrum disorders (ASD) are associated with high services use, but European data on costs are scarce. Objectives Utilisation and annual costs of 385 individuals with ASD (aged 4-67 years; 18.2% females; 37.4% IQ < 85) from German outpatient clinics were assessed. Methods Client Service Receipt Inventory Results Average annual costs per person were 3287 EUR, with psychiatric inpatient care (19.8%), pharmacotherapy (11.1%), and occupational therapy (11.1%) being the largest cost components. Females incurred higher costs than males (4864 EUR vs. 2936 EUR). In a regression model, female sex (Cost Ratio: 1.65), lower IQ (1.90), and Asperger syndrome (1.54) were associated with higher costs. Conclusions In conclusion, ASD-related health costs are comparable to those of schizophrenia, thus underlining its public health relevance. Higher costs in females demand further research. Disclosure No significant relationships.

Keywords